Amar U. Kishan

7.2k total citations · 2 hit papers
157 papers, 2.5k citations indexed

About

Amar U. Kishan is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Amar U. Kishan has authored 157 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 119 papers in Pulmonary and Respiratory Medicine, 66 papers in Radiation and 45 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Amar U. Kishan's work include Prostate Cancer Diagnosis and Treatment (98 papers), Prostate Cancer Treatment and Research (95 papers) and Advanced Radiotherapy Techniques (66 papers). Amar U. Kishan is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (98 papers), Prostate Cancer Treatment and Research (95 papers) and Advanced Radiotherapy Techniques (66 papers). Amar U. Kishan collaborates with scholars based in United States, Canada and United Kingdom. Amar U. Kishan's co-authors include Michael L. Steinberg, Minsong Cao, Nicholas G. Nickols, Christopher R. King, Jérémie Calais, Daniel E. Spratt, Patrick A. Kupelian, Nicholas G. Zaorsky, Robert E. Reiter and Daniel A. Low and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Cell and Scientific Reports.

In The Last Decade

Amar U. Kishan

145 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Magnetic Resonance Imaging–Guided vs Computed Tomography–Guided Stereotactic Body Radiotherapy for Prostate Cancer

2023 148 citations Amar U. Kishan, Ting Martin et al. profile →
PSMA-PET/CT Findings in Patients With High-Risk Biochemically Recurrent Prostate Cancer With No Metastatic Disease by Conventional Imaging

2025 19 citations Nicholas G. Nickols, Amar U. Kishan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amar U. Kishan United States	22	1.5k	870	832	367	346	157	2.5k
Carlo Greco Italy	25	1.2k 0.8×	758 0.9×	1.0k 1.2×	402 1.1×	233 0.7×	141	2.4k
Gregory S. Sibley United States	19	1.5k 1.0×	976 1.1×	999 1.2×	604 1.6×	291 0.8×	41	2.6k
Elisabeth Kjellén Sweden	28	1.5k 1.0×	747 0.9×	909 1.1×	330 0.9×	473 1.4×	120	3.1k
Daniel Habermehl Germany	35	1.4k 0.9×	821 0.9×	601 0.7×	192 0.5×	323 0.9×	115	3.0k
Mark V. Mishra United States	25	972 0.6×	418 0.5×	313 0.4×	253 0.7×	381 1.1×	145	2.1k
Jeffrey Meyer United States	23	790 0.5×	713 0.8×	557 0.7×	227 0.6×	249 0.7×	125	2.3k
Wayne H. Pinover United States	22	1.7k 1.1×	951 1.1×	428 0.5×	407 1.1×	187 0.5×	53	2.4k
D.A. Loblaw Canada	29	2.5k 1.6×	877 1.0×	487 0.6×	306 0.8×	307 0.9×	88	3.4k
Varagur Venkatesan Canada	22	1.6k 1.1×	642 0.7×	273 0.3×	453 1.2×	176 0.5×	47	2.4k
T.A. DeWees United States	35	1.7k 1.1×	1.1k 1.3×	1.1k 1.4×	281 0.8×	403 1.2×	174	3.9k

Countries citing papers authored by Amar U. Kishan

Since Specialization

Citations

This map shows the geographic impact of Amar U. Kishan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amar U. Kishan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amar U. Kishan more than expected).

Fields of papers citing papers by Amar U. Kishan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amar U. Kishan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amar U. Kishan. The network helps show where Amar U. Kishan may publish in the future.

Co-authorship network of co-authors of Amar U. Kishan

This figure shows the co-authorship network connecting the top 25 collaborators of Amar U. Kishan. A scholar is included among the top collaborators of Amar U. Kishan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amar U. Kishan. Amar U. Kishan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fendler, Wolfgang P., Matthias Eiber, Boris Hadaschik, et al.. (2024). Randomized Trial of Prostate-Specific Membrane Antigen PET/CT Before Definitive Radiotherapy for Unfavorable Intermediate- and High-Risk Prostate Cancer (PSMA-dRT Trial). Journal of Nuclear Medicine. 65(7). 1076–1079. 5 indexed citations

Rieger, Angela C., Andrea Farolfi, Amar U. Kishan, et al.. (2024). Prostate-Specific Membrane Antigen PET/CT–Guided, Metastasis-Directed Radiotherapy for Oligometastatic Castration-Resistant Prostate Cancer. Journal of Nuclear Medicine. 65(9). 1387–1394. 6 indexed citations

Valle, Luca, A.A. Rosenbloom, Nicholas G. Zaorsky, et al.. (2024). American Radium Society Appropriate Use Criteria for the Workup and Treatment of Local Intraprostatic Recurrence of Prostate Cancer Following Definitive Radiotherapy. European Urology Oncology. 8(3). 796–804. 1 indexed citations

Rettig, Matthew B., John Shen, Robert E. Reiter, et al.. (2024). Systemic and Tumor-directed Therapy for Oligorecurrent Metastatic Prostate Cancer (SATURN): Primary Endpoint Results from a Phase 2 Clinical Trial. European Urology. 85(6). 517–520. 10 indexed citations

Tward, Jonathan D., Alexander Gutin, Chelsea R. Kasten, et al.. (2024). Using the Cell-Cycle Risk Score to Predict the Benefit of Androgen-Deprivation Therapy Added to Radiation Therapy in Patients With Newly Diagnosed Prostate Cancer. JCO Precision Oncology. 8(8). e2300722–e2300722. 2 indexed citations

Weiner, Adam B., et al.. (2024). International Variations in Adherence to Quality Metrics for Locoregional Prostate Cancer. European Urology Oncology. 7(6). 1469–1477.

Henke, Lauren E., A. Bruynzeel, Filippo Alongi, et al.. (2024). Patient-Reported Outcomes Following Magnetic Resonance-Guided Radiation Therapy for Prostate Cancer: A Systematic Review and Meta-Analysis. International Journal of Radiation Oncology*Biology*Physics. 120(1). 38–48. 2 indexed citations

Neilsen, Beth K., Minsong Cao, Yingli Yang, et al.. (2023). Dosimetric predictors for genitourinary toxicity in MR‐guided stereotactic body radiation therapy (SBRT): Substructure with fraction‐wise analysis. Medical Physics. 51(1). 612–621. 5 indexed citations

Roy, Soumyajit, Yilun Sun, Christopher J.D. Wallis, et al.. (2023). Prognostic Role of Dynamic Changes in Serological Markers in Metastatic Hormone Naïve Prostate Cancer. Cancers. 15(17). 4392–4392. 5 indexed citations

10.

Kishan, Amar U., Minsong Cao, Ricky R. Savjani, et al.. (2023). Clinical Implementation of Weak Magnetic Field Generator in Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 117(2). e701–e702. 1 indexed citations

11.

Lui, Asona, Matthew S. Katz, Alejandro Berlín, et al.. (2023). Use of Focal Radiotherapy Boost for Prostate Cancer and Perceived Barriers toward its Implementation: A Survey. International Journal of Radiation Oncology*Biology*Physics. 117(2). e454–e455. 2 indexed citations

12.

Ong, Wee Loon, Holly Wilhalme, Jeremy Millar, et al.. (2023). 34 Testosterone Recovery Following Androgen Suppression and Prostate Radiotherapy (Transport) - Updated Analyses from the MARCAP Consortium. Radiotherapy and Oncology. 186. S18–S18. 1 indexed citations

13.

Romero, Tahmineh, Matthew B. Rettig, Michael L. Steinberg, et al.. (2022). Significant changes in macrophage and CD8 T cell densities in primary prostate tumors 2 weeks after SBRT. Prostate Cancer and Prostatic Diseases. 26(1). 207–209. 10 indexed citations

14.

Roy, Soumyajit, Scott C. Morgan, Christopher J.D. Wallis, et al.. (2022). Association of dynamic change in patient-reported pain with survival in metastatic castrate sensitive prostate cancer—exploratory analysis of LATITUDE study. Prostate Cancer and Prostatic Diseases. 26(1). 96–104. 3 indexed citations

15.

McCloskey, Susan A., Ann C. Raldow, Amar U. Kishan, et al.. (2022). Developing a Mobile Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Administration System to Capture Postradiation Toxicity in Oncology: Usability and Feasibility Study. JMIR Formative Research. 6(4). e27775–e27775. 2 indexed citations

16.

Alshalalfa, Mohammed, Idalid Franco, Randy Vince, et al.. (2022). Clinicogenomic characterization of prostate cancer liver metastases. Prostate Cancer and Prostatic Diseases. 25(2). 366–369. 13 indexed citations

17.

Zaorsky, Nicholas G., Jérémie Calais, Stefano Fanti, et al.. (2021). Salvage therapy for prostate cancer after radical prostatectomy. Nature Reviews Urology. 18(11). 643–668. 29 indexed citations

18.

Jiang, Naomi, Donald B. Fuller, Andrew Loblaw, et al.. (2021). Stereotactic Body Radiotherapy for High-Risk Localized Carcinoma of the Prostate (SHARP) Consortium: Analysis of 344 Prospectively Treated Patients. International Journal of Radiation Oncology*Biology*Physics. 110(3). 731–737. 40 indexed citations

19.

Kishan, Amar U., et al.. (2019). MicroRNA-based Biomarkers predicting Long-Term Toxicity to Prostate SBRT. International Journal of Radiation Oncology*Biology*Physics. 105(1). S39–S40. 2 indexed citations

20.

Kishan, Amar U. & Percy Lee. (2016). MRI-guided radiotherapy: Opening our eyes to the future. 3(2). 420–427. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact